This resolution (H. Res. 704) instructs the House’s sense that the Center for Medicare and Medicaid Innovation’s Wasteful and Inappropriate Services Reduction (WISeR) Model should not be implemented because it would undermine beneficiary access to care.
It gathers a set of factual findings about the model’s design — including expanded prior authorization, use of private vendors, and AI technologies — and urges the Centers for Medicare & Medicaid Services to terminate the experiment.
The measure is symbolic, not statutory: it expresses disapproval, lists findings about access and vendor performance, and makes a formal request to CMS. For stakeholders in Medicare — from beneficiaries and clinicians to CMMI, CMS leadership, and private prior-authorization vendors — the resolution signals congressional scrutiny of using Medicare to scale private-sector utilization management practices and algorithmic decision tools.
At a Glance
What It Does
The resolution records the House’s disapproval of the WISeR Model, enumerates evidence and concerns about the model, and formally requests that CMS terminate WISeR. It does not change statute or regulate CMS; it communicates congressional judgment and creates political pressure.
Who It Affects
Traditional Medicare beneficiaries and clinicians would be most directly implicated by the WISeR design the resolution criticizes. It also targets CMMI and CMS decisionmaking, private prior-authorization vendors that would execute the model, and Medicare Advantage plans whose practices the model would import into fee-for-service Medicare.
Why It Matters
The bill frames a debate about whether CMMI can or should import private-sector utilization-management techniques — including algorithmic review — into traditional Medicare. That dispute touches oversight of CMMI, the use of AI in eligibility and coverage decisions, and how Congress signals limits on administratively tested delivery reforms.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The resolution responds to a CMMI proposal called the Wasteful and Inappropriate Services Reduction (WISeR) Model. According to the bill text, WISeR would expand prior authorization requirements in traditional (fee-for-service) Medicare, turn to private companies that currently handle prior authorization for private plans, and deploy enhanced technologies such as artificial intelligence and machine learning to process those requests.
The resolution assembles evidence and stakeholder claims—about prior authorization’s effect on timely care, clinician burnout, overturn rates on appeal, and reported error rates in some AI tools—to ground its objection.
H. Res. 704 contains three operative impulses: (1) it formally expresses disapproval of the WISeR Model, (2) it finds that applying Medicare Advantage–style prior authorization in traditional Medicare undermines beneficiary access, and (3) it strongly requests that CMS terminate the WISeR Model.
Because this is a House sense resolution, it does not direct CMS by statute; its practical effect is to register congressional opposition and increase political and oversight pressure.The resolution references specific performance concerns about the private vendors targeted for the model and about AI tools reported in industry press. That matters because the WISeR design contemplates outsourcing expanded utilization review to firms with existing contracts and then automating parts of the review pipeline.
The resolution therefore raises three connected implementation questions it does not resolve: how services would be selected for added prior authorization, what safeguards would govern algorithmic review, and what appeals or monitoring mechanisms would prevent erroneous denials from harming access.Finally, the bill was referred to the House Ways and Means Committee and the Committee on Energy and Commerce for consideration of applicable jurisdictional provisions. Practically, the resolution is a political instrument: it collects a record of objections that committees, CMS, and stakeholders can point to in hearings, correspondence, or rulemaking deliberations without changing existing law.
The Five Things You Need to Know
The resolution identifies January 1, 2026 as the proposed WISeR model start date in CMMI’s design documents.
WISeR would increase the number of services subject to prior authorization in traditional Medicare by 30 percent, according to the bill text.
The model proposes contracting with private prior-authorization vendors that currently serve private insurers, including Medicare Advantage companies.
WISeR contemplates using enhanced technologies — explicitly including artificial intelligence and machine learning — to process the expanded prior-authorizations.
H. Res. 704 is nonbinding: it expresses disapproval, records findings that prior authorization undermines access, and ‘strongly requests’ CMS terminate WISeR rather than imposing a statutory prohibition.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Factual findings and evidence the House relies on
The preamble collects the factual predicates the resolution uses: CMMI’s WISeR proposal, the planned expansion of prior authorization, reliance on private vendors and AI, and cited evidence from the American Medical Association, CMS datasets, the Kaiser Family Foundation, and press reporting. Practically, compiling those findings creates a congressional record that opponents can cite in oversight letters and hearings; it also frames the debate around access, vendor accuracy, and technology risk rather than cost containment alone.
Formal expression of disapproval
This clause states the House’s disapproval of the WISeR Model. As a sense resolution, that language has no legal force but signals political opposition. For CMS and CMMI leaders, a formal House disapproval raises the reputational and oversight costs of proceeding with the model and can prompt additional hearings or conditionalities in future appropriations or oversight actions.
Findings that expanded prior authorization undermines access
The resolution finds that transplanting prior-authorization processes from Medicare Advantage to traditional Medicare undermines beneficiaries’ timely access to care. That finding anchors the political argument around patient harm and clinician burden, and it narrows the policy question to whether utilization management techniques that are standard in private plans are acceptable in a publicly administered program.
Request that CMS terminate the WISeR Model
The resolution ‘strongly requests’ that CMS terminate WISeR. The phrasing is a nonbinding exhortation rather than a directive; it cannot compel agency action but formalizes congressional opposition and places a public expectation on CMS leadership. Agencies typically treat such resolutions as signals that may influence internal risk-benefit calculations or the timing and transparency of any model roll‑out.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Traditional Medicare beneficiaries — the resolution seeks to preserve current access by opposing a model that would expand prior authorization, reducing the risk of administrative delays and coverage denials for fee‑for‑service enrollees.
- Physicians and clinicians — by opposing an expansion of prior authorization and highlighting clinician burnout, the resolution advances the interests of providers who contend with authorization burdens and appeal workloads.
- Patient advocacy organizations and consumer groups — the resolution validates advocacy arguments about access and algorithmic risk and strengthens their leverage in oversight and public messaging.
- Small and rural providers — these providers tend to be more exposed to cashflow and administrative strains from increased prior authorization; blocking the model would avoid potential revenue disruption and staffing pressure.
Who Bears the Cost
- CMMI and CMS leadership — the resolution increases political and oversight pressure, potentially constraining CMMI’s flexibility to test delivery reforms and forcing additional administrative responses or pauses.
- Private prior-authorization vendors targeted for WISeR — if the model is terminated, vendors lose a potential large government contract and market expansion opportunity.
- Medicare Advantage plans and their utilization-management vendors — the resolution challenges the export of MA-style controls into traditional Medicare, which could slow convergence of prior-authorization norms across programs.
- Congressional committee staff and oversight offices — the resolution generates follow‑up work (hearings, document requests, investigations) that will require staff time and resources to pursue the issues raised.
Key Issues
The Core Tension
The central dilemma is legitimate: policymakers must balance the public interest in reducing wasteful or inappropriate medical services against the equally weighty obligation to protect timely access to necessary care—especially for traditional Medicare beneficiaries who rely on a publicly administered program. The resolution addresses the latter concern by urging termination, but doing so risks foreclosing carefully designed tests that might curb waste if accompanied by strong transparency, audit, appeals, and algorithmic‑risk controls.
Two implementation trade-offs drive the policy tension here. First, CMMI’s statutory mission is to test models that reduce costs and improve quality; prior authorization is a long‑used tool for controlling inappropriate utilization.
The resolution treats prior authorization expansion as primarily an access problem, but it does not engage the underlying question of whether narrower, better‑designed utilization controls could reduce waste without harming patients. The text also does not identify alternative guardrails (service selection criteria, expedited-appeal timelines, or monitoring metrics) that would allow targeted prior authorization with fewer access risks.
Second, the resolution leans heavily on selective sources and headline statistics to justify termination—AMA survey results on clinician burnout, overturn rates on appeal, and press reports of AI error rates. Those citations raise legitimate concerns but also leave open empirical questions the bill does not resolve: how representative are the vendor error rates, how would production-grade AI systems compare to experimental tools, and how would appeals and remediation be structured under WISeR?
Because the resolution is nonbinding, it functions mainly as political pressure; that can lead to one of two unintended outcomes—either (a) CMMI scraps an expensive but potentially controllable experiment without exploring mitigations, or (b) it proceeds but faces protracted oversight battles that distract from careful implementation.
Finally, the resolution does not address crucial technical and procurement details: which specific services would be added, how private vendors would be selected and audited, whether algorithmic decisions must be explainable, and what patient‑level monitoring would trigger immediate suspension. Those gaps are the real levers for policy design; a blanket request to terminate avoids hard trade‑offs but leaves the system without a path to safely test whether prior authorization plus robust safeguards can reduce unnecessary care without creating new access harms.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.